CT scanning has provided critical information on the progression of the severity of the disease on COVID-19 patients. This article, published on March 25, 2021, provides an overview of the progression of the disease by referencing generalized curves of lung opacity volume and density over time for 739 COVID-19 patients, who undertook CTs and over 270 laboratory measurements.
Note: You are leaving the NeuroLogica website. By selecting CONTINUE, you will be re-directed to Samsung Healthcare Global Website.
Some of the products and features on this website are not cleared for use and not available for purchase in the United States.